Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yeru Tan"'
Autor:
Xiuqing Lu, Chao Zhang, Lewei Zhu, Sifen Wang, Lijun Zeng, Wenjing Zhong, Xuxia Wu, Qi Yuan, Hailin Tang, Shien Cui, Yeru Tan, Yuehua Li, Weidong Wei
Publikováno v:
Advanced Science, Vol 11, Iss 47, Pp n/a-n/a (2024)
Abstract Breast cancer (BC) is a common malignancy that affects women worldwide. Although transducing beta‐like 2 (TBL2), a member of the WD40 repeat protein family, has been implicated in various intracellular signaling pathways, its precise funct
Externí odkaz:
https://doaj.org/article/60f8922a631346529072cf07536e6786
Autor:
Baohong Jiang, Sixuan Wu, Lijun Zeng, Yuanbin Tang, Lunqi Luo, Lianjie Ouyang, Wenjie Feng, Yeru Tan, Yuehua Li
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-21 (2024)
Abstract Background Breast cancer is a major global health concern, and there is a continuous search for novel biomarkers to predict its prognosis. The mitochondrial protein NDUFAF6, previously studied in liver cancer, is now being investigated for i
Externí odkaz:
https://doaj.org/article/5489beb9525e469dac3fa7f19a1171ac
Autor:
Xiaowen Qi, Zhixing Wan, Baohong Jiang, Yuhan Ouyang, Wenjie Feng, Hongbo Zhu, Yeru Tan, Rongfang He, Liming Xie, Yuehua Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Breast cancer is the most common type of malignancy among women. Due to the iron-dependent character of breast cancer cells, they are more sensitive to ferroptosis compared to normal cells. It is possible to reverse tumor resistance by inducing ferro
Externí odkaz:
https://doaj.org/article/0091f8696393469cad48bef9ea278ba1
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Osteosarcoma is a highly malignant solid tumor with poor prognosis, early metastasis, and rapid progression and has a high mortality rate, in which better therapeutic strategies are needed. Circ0038632, also known as circPLK1, is a tumor promotor in
Externí odkaz:
https://doaj.org/article/cf12aa86c8914de98b7a32c64e8a5f0d
Autor:
Yuehua Li, Baohong Jiang, Hongbo Zhu, Xiaofei Qu, Liqin Zhao, Yeru Tan, Yiling Jiang, Mingchu Liao, Xiaoping Wu
Publikováno v:
Tumor Biology, Vol 39 (2017)
This study explored the mechanism underlying long non-coding RNA ROR regulating autophagy on Tamoxifen resistance in breast cancer. Cancer tissues and adjacent normal tissues were collected from 74 breast cancer patients. Human breast cancer BT474 ce
Externí odkaz:
https://doaj.org/article/4a646d7432bc414fb12b94c0859061e4
Publikováno v:
Journal of Oncology. 2023:1-13
Background. It is well known that cancer stem cells can induce cancer metastasis, which causes the majority of cancer-related death, especially in triple-negative breast cancer (TNBC). TNBC features a high metastatic rate and low metastasis-free surv
Autor:
Yuehua Li, Ting Gao, Fuqiang Gong, Liming Xie, Xiaoping Wu, Baohong Jiang, Liting Tang, Yu Zhou, Hongbo Zhu, Yeru Tan
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 22:1723-1734
Background: Cancer stem cells could influence tumor recurrence and metastasis. Objective: To develop a new effective treatment modality targeting breast cancer stem cells (BCSCs) and to explore the role of Apatinib in BCSCs. Methods: BCSCs were isola
Publikováno v:
Current Cancer Drug Targets. 21:860-869
Background: The function of MALAT1, a long non-coding RNAs (lncRNA), in HER2- positive breast cancer remains largely unexplored. Objectives: This study aimed to investigate the effect of MALAT1 on tumor development in HER2-positive breast cancer. Met
Publikováno v:
Journal of oncology. 2022
Gastric cancer (GC) is one of the most prevalent malignancies in the digestive system across the world. The function and mechanism of PDLIM1, a cancer-suppressing gene, in gastric cancer progression remain unclear. This study is aimed at investigatin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
The purpose of this study was to explore the curative effect and safety of hyperfractionated accelerated radiotherapy (HART) and conventional fractionated radiotherapy (CFRT) combined with EP chemotherapy regimen in the treatment of limited-stage sma